Czech scientists test psilocybin therapy for depression in multiple sclerosis patients as part of the international PsyPal study.

Cambridge researchers map the convergence of biomarkers, digital phenotyping, and AI toward biologically grounded ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, FDA alignment and a DSMB recommendation. Patients that received 20mg ...

Trial examines whether Albuquerque police should have intervened more to prevent a 29-year-old woman’s 2021 self-inflicted death.

Professors are calling out the alarming rise in students diagnosed as “disabled” at elite universities to get special accommodations in class and on exams. One in five students at Brown and Harvard ...

Spring Health reports that whole person mental health integrates mental and physical care, improving employee wellbeing and reducing healthcare costs.

A new synthesis finds that common epilepsies are driven by thousands of tiny-effect genetic variants, most still ...

The new pricing structure is made available as of February for 32,13 SEK per day at pharmacies throughout Sweden ...

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025In post hoc analysis of the pivotal RESILIENT ...